Prem Seth

8.4k total citations
140 papers, 7.2k citations indexed

About

Prem Seth is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Prem Seth has authored 140 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 71 papers in Oncology and 64 papers in Genetics. Recurrent topics in Prem Seth's work include Virus-based gene therapy research (63 papers), Cancer-related Molecular Pathways (53 papers) and Cancer Research and Treatments (45 papers). Prem Seth is often cited by papers focused on Virus-based gene therapy research (63 papers), Cancer-related Molecular Pathways (53 papers) and Cancer Research and Treatments (45 papers). Prem Seth collaborates with scholars based in United States, Canada and China. Prem Seth's co-authors include Kenneth H. Cowan, Ira Pastan, Mark C. Willingham, Dai Katayose, Christopher J. Froelich, Robert P. Wersto, Zhuangwu Li, Amol N.S. Rakkar, Hui Zhang and Shiv Srivastava and has published in prestigious journals such as Science, JAMA and Journal of Biological Chemistry.

In The Last Decade

Prem Seth

139 papers receiving 7.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prem Seth United States 50 4.5k 3.1k 2.2k 967 915 140 7.2k
Timothy F. Lane United States 44 4.6k 1.0× 2.0k 0.6× 1.7k 0.8× 1.4k 1.4× 415 0.5× 69 8.9k
Terry Van Dyke United States 40 4.5k 1.0× 3.0k 0.9× 1.3k 0.6× 1.1k 1.1× 638 0.7× 104 7.2k
Richard N. Harkins United States 30 3.8k 0.8× 1.3k 0.4× 1.2k 0.6× 925 1.0× 438 0.5× 58 7.4k
Samuel Benchimol Canada 46 5.7k 1.3× 4.6k 1.5× 971 0.4× 1.4k 1.4× 1.2k 1.3× 94 8.8k
Brian P. Sorrentino United States 44 5.4k 1.2× 3.7k 1.2× 2.4k 1.1× 635 0.7× 160 0.2× 108 8.6k
Akira Horii Japan 55 6.1k 1.3× 4.2k 1.3× 1.2k 0.6× 2.2k 2.2× 341 0.4× 271 11.0k
James M. Roberts United States 40 7.2k 1.6× 4.8k 1.5× 1.1k 0.5× 1.0k 1.1× 415 0.5× 52 9.6k
Yoshito Ueyama Japan 41 3.2k 0.7× 2.6k 0.8× 684 0.3× 1.0k 1.0× 292 0.3× 198 6.5k
Tim Crook United Kingdom 54 6.5k 1.4× 5.2k 1.7× 1.2k 0.6× 2.3k 2.4× 1.3k 1.4× 120 11.1k
Scott L. Weinrich United States 22 7.6k 1.7× 1.5k 0.5× 1.4k 0.7× 728 0.8× 1.6k 1.8× 36 12.6k

Countries citing papers authored by Prem Seth

Since Specialization
Citations

This map shows the geographic impact of Prem Seth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prem Seth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prem Seth more than expected).

Fields of papers citing papers by Prem Seth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prem Seth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prem Seth. The network helps show where Prem Seth may publish in the future.

Co-authorship network of co-authors of Prem Seth

This figure shows the co-authorship network connecting the top 25 collaborators of Prem Seth. A scholar is included among the top collaborators of Prem Seth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prem Seth. Prem Seth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Li, Yuxiang, Fengjun Xiao, Aimei Zhang, et al.. (2020). Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer. Cellular Immunology. 348. 104041–104041. 69 indexed citations
4.
Wang, Hao, Weidong Xu, Tao Wang, et al.. (2018). Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model. Human Gene Therapy. 30(2). 197–210. 22 indexed citations
5.
Xu, Weidong, Thomas Neill, Yang� Yang, et al.. (2014). The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer. Gene Therapy. 22(3). 247–256. 76 indexed citations
6.
Hu, Zebin, Zhenwei Zhang, Arthur Berg, et al.. (2012). Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model. Human Gene Therapy. 23(8). 871–882. 56 indexed citations
7.
8.
Seth, Prem. (2005). Vector-mediated cancer gene therapy: An overview. Cancer Biology & Therapy. 4(5). 512–517. 61 indexed citations
9.
Ala‐aho, Risto, Reidar Grénman, Prem Seth, & Veli‐Matti Kähäri. (2002). Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Oncogene. 21(8). 1187–1195. 59 indexed citations
10.
11.
Matsuo, Tatsuya, Prem Seth, & Carol J. Thiele. (2001). Increased expression of p27Kip1 arrests neuroblastoma cell growth. Medical and Pediatric Oncology. 36(1). 97–99. 16 indexed citations
12.
Seth, Prem, et al.. (2000). Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. Journal of Cellular Biochemistry. 76(2). 270–279. 44 indexed citations
13.
Zou, Zhiqiang, Chunling Gao, Akhilesh K. Nagaich, et al.. (2000). p53 Regulates the Expression of the Tumor Suppressor Gene Maspin. Journal of Biological Chemistry. 275(9). 6051–6054. 230 indexed citations
14.
Scheinman, Marcel, et al.. (1999). p53 gene transfer to the injured rat carotid artery decreases neointimal formation. Journal of Vascular Surgery. 29(2). 360–369. 39 indexed citations
15.
Zhang, Lijuan, Min Kim, Yung Hyun Choi, et al.. (1999). Diminished G1 Checkpoint after γ-Irradiation and Altered Cell Cycle Regulation by Insulin-like Growth Factor II Overexpression. Journal of Biological Chemistry. 274(19). 13118–13126. 22 indexed citations
16.
Auer, Kelly L., Mark S. Spector, Robert M. Tombes, et al.. (1998). α‐Adrenergic inhibition of proliferation in HepG2 cells stably transfected with the α1B‐adrenergic receptor through a p42MAP kinase/p21Cip1/WAF1‐dependent pathway. FEBS Letters. 436(1). 131–138. 25 indexed citations
17.
Kim, Min, Yu Katayose, Qingdi Li, et al.. (1998). Recombinant Adenovirus Expressing Von Hippel-Lindau-Mediated Cell Cycle Arrest Is Associated with the Induction of Cyclin-Dependent Kinase Inhibitor p27Kip1. Biochemical and Biophysical Research Communications. 253(3). 672–677. 48 indexed citations
18.
Talanian, Robert V., Jane M. Turbov, Prem Seth, et al.. (1997). Granule-mediated Killing: Pathways for Granzyme B–initiated Apoptosis. The Journal of Experimental Medicine. 186(8). 1323–1331. 157 indexed citations
19.
Xiao, Xiangwei, et al.. (1997). Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53. Gene Therapy. 4(7). 675–682. 35 indexed citations
20.
Katayose, Dai, Robert P. Wersto, Kenneth H. Cowan, & Prem Seth. (1995). Consequences of p53 Gene Expression by Adenovirus Vector on Cell Cycle Arrest and Apoptosis in Human Aortic Vascular Smooth Muscle Cells. Biochemical and Biophysical Research Communications. 215(2). 446–451. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy F. Lane Breakdown of academic impact, for papers by Terry Van Dyke Breakdown of academic impact, for papers by Richard N. Harkins Breakdown of academic impact, for papers by Samuel Benchimol Breakdown of academic impact, for papers by Brian P. Sorrentino Breakdown of academic impact, for papers by Akira Horii Breakdown of academic impact, for papers by James M. Roberts Breakdown of academic impact, for papers by Yoshito Ueyama Breakdown of academic impact, for papers by Tim Crook Breakdown of academic impact, for papers by Scott L. Weinrich
Rankless by CCL
2026